B-RafV600E Cooperates With Alternative Spliced Rac1b to Sustain Colorectal Cancer Cell Survival

Gastroenterology

Volumn 135, Issue 3, 2008, Pages 899-906

  Matos, Paulo ^a   Oliveira, Carla ^b,c   Velho, Sérgia ^b   Gonçalves, Vânia ^a   da Costa, Luís Teixiera ^b   Moyer, Mary Pat ^d   Seruca, Raquel ^b,c   Jordan, Peter ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c University of Porto   (Portugal)

^d INCELL Corporation ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; MESSENGER RNA; RAC1 PROTEIN;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; BRAF GENE; CANCER CELL; CELL CYCLE PROGRESSION; CELL SURVIVAL; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KRAS GENE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 51249098983     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.05.052     Document Type: Article

References (29)

1. Andreyev H.J., Norman A.R., Cunningham D., et al. Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study. J Natl Cancer Inst 90 (1998) 675-684
2. Oliveira C., Velho S., Moutinho C., et al. KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression. Oncogene 26 (2007) 158-163
3. Downward J. Targeting ras signaling pathways in cancer therapy. Nat Rev Cancer 3 (2003) 11-22
4. Cox A.D., and Der C.J. The dark side of Ras: regulation of apoptosis. Oncogene 22 (2007) 8999-9006
5. Khosravi-Far R., Solski P.A., Clark G.J., et al. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol Cell Biol 15 (1995) 6443-6453
6. Qiu R.G., Chen J., Kirn D., et al. An essential role for Rac in Ras transformation. Nature 374 (1995) 457-459
7. Joneson T., and Bar-Sagi D. Suppression of Ras-induced apoptosis by the Rac GTPase. Mol Cell Biol 19 (1999) 5892-5901
8. Malliri A., van der Kammen R.A., Clark K., et al. Mice deficient for the Rac activator Tiam1 are resistant to Ras-induced skin tumors. Nature 417 (2002) 867-871
9. Joyce D., Bouzahzah B., Fu M., et al. Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway. J Biol Chem 274 (1999) 25245-25249
10. Hinz M., Krappmann D., Eichten A., et al. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol 19 (1999) 2690-2698
11. Guttridge D.C., Albanese C., Reuther J.Y., et al. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19 (1999) 5785-5799
12. Davies H., Bignell G.R., Cox C., et al. Mutations in the BRAF gene in human cancer. Nature 417 (2002) 949-954
13. Oliveira C., Pinto M., Duval A., et al. BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency. Oncogene 22 (2003) 9192-9196
14. Shen L., Toyota M., Kondo Y., et al. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A 104 (2007) 18654-18659
15. Dhomen N., and Marais R. New insight into BRAF mutations in cancer. Curr Opin Genet Dev 17 (2007) 31-39
16. Jordan P., Brazão R., Boavida M.G., et al. Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Oncogene 18 (1999) 6835-6839
17. Matos P., Collard J.G., and Jordan P. Tumor-related alternative-spliced Rac1b is not regulated by Rho-GDI and exhibits selective downstream signaling. J Biol Chem 278 (2003) 50442-50448
18. Fiegen D., Haeusler L.C., Blumenstein L., et al. Alternative splicing of Rac1 generates Rac1b, a self-activating GTPase. J Biol Chem 279 (2004) 4743-4749
19. Radisky D.C., Levy D.D., Littlepage L.E., et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436 (2005) 123-127
20. Matos P., and Jordan P. Expression of Rac1b stimulates NF-kB-mediated cell survival and G1/S-progression. Exp Cell Res 305 (2005) 292-299
21. Matos P., and Jordan P. Rac1, but not Rac1b, stimulates RelB-mediated gene transcription in colorectal cancer cells. J Biol Chem 281 (2006) 13724-13732
22. Moyer M.P., Manzano L.A., Merriman R.L., et al. NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell Dev Biol Anim 32 (1996) 315-317
23. Hingorani S.R., Jacobetz M.A., Robertson G.P., et al. Suppression of BRAF(V599E) in human melanoma abrogates transformation. Cancer Res 63 (2003) 5198-5202
24. Panka D.J., Atkins M.B., and Mier J.W. Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma. Clin Cancer Res 12 (2006) 2371s-2375s
25. Soares P., Trovisco V., Rocha A.S., et al. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22 (2003) 4578-4580
26. Schnelzer A., Prechtel D., Knaus U., et al. Rac1 in human breast cancer: overexpression, mutation analysis, and characterisation of a new isoform, Rac1b. Oncogene 19 (2000) 3013-3020
27. Singh A., Karnoub A.E., Palmby T.R., et al. Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation. Oncogene 23 (2004) 9369-9380
28. Esufali S., Charames G.S., Pethe V.V., et al. Activation of tumor-specific splice variant Rac1b by Dishevelled promotes canonical Wnt signaling and decreased adhesion of colorectal cancer cells. Cancer Res 67 (2007) 2469-2479
29. Fang J.Y., and Richardson B.C. The MAPK signaling pathways and colorectal cancer. Lancet Oncol 6 (2005) 322-327